Watch our Facebook Session from January 25, where FBC’s Research and Education Team, Dr. Mary Sunderland and Dr. Chad Andrews, discussed four vision research and treatment trends to watch for in 2018!…Read More
With the December 2017 announcement that the world’s first ocular gene therapy had received approval by the U.S. Food and Drug Administration (FDA), there’s no doubt that 2017 was a landmark year…Read More
Today we are celebrating the FDA’s pathbreaking approval of Luxturna. We have been following the development of Luxturna closely. Today’s landmark FDA approval makes Luxturna the first gene therapy approved in the…Read More
In many retinal diseases, vision loss occurs when cells that are crucial for vision are damaged or lost. This is the case, for example, in age-related macular degeneration (AMD), retinitis pigmentosa, choroideremia,…Read More
In medicine, innovative treatments don’t emerge out of thin air. They are the result of a series of advancements in our understanding of how genes, molecules, and cells interact. The human eye…Read More
Stem cell therapy has emerged as one of the most promising approaches in the fight to end blindness, and Dr. Gilbert Bernier’s research has played an enormous role in pushing the field…Read More
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our eNews.